Our product range spans a wide area, encompassing intravenous medications, infusion therapy, clinical nutrition, and the medical devices necessary for their application. In the biosimilar field, we specialize in autoimmune diseases and oncology. In 2019, Fresenius Kabi successfully launched its first biosimilar product. In the realm of transfusion medicine and cell therapy devices, Fresenius Kabi offers blood component collection and in vitro cell therapy products.